FDA record
Obesity and weight management
4 drugs, each read from FDA's own review documents and label.
| Drug | Sponsor | First approved | FDA documents |
|---|---|---|---|
| Foundayoorforglipron calcium | Eli Lilly and Co. | April 1, 2026 | 12 |
| Mounjarotirzepatide | Eli Lilly and Co. | May 13, 2022 | 34 |
| Wegovysemaglutide | Novo | June 4, 2021 | 44 |
| Trulicitydulaglutide | Eli Lilly and Co. | September 18, 2014 | 47 |
Being checked before publication: bupropion_naltrexone_nda200063, exenatide_nda209210, exenatide_nda22200, insulin_liraglutide_bla208583, insulin_lixisenatide_bla208673, liraglutide_nda206321, liraglutide_nda22341, lixisenatide_bla208471, phentermine_topiramate_nda22580, semaglutide_nda209637, semaglutide_nda213051, semaglutide_nda213182, semaglutide_nda218316, setmelanotide_nda213793, tirzepatide_nda217806.